A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
A treatment is being testedPhase 3
Running in: SC Memorial Healthcare International SRL, București · Cardiomed SRL Cluj-Napoca, Cluj-Napoca · Affidea Constanța, Constanța · Centrul de Oncologie "Sfântul Nectarie", Craiova · SC Radiotherapy Center Cluj SRL, Florești · S.C. Centrul de Oncologie Euroclinic S.R.L., Iași — and 3 more
See the official record ↗ NCT06875310
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A treatment is being testedPhase 3
Running in: Centrul Medical de Diagnostic si Tratament Ambulator Neomed SRL /ID# 240826, Brașov · Cardiomed Srl /Id# 255320, Cluj-Napoca · Sc Oncolab Srl /Id# 239105, Craiova · Institutul Regional de Oncologie /ID# 254065, Iași · Spitalul Pelican /ID# 254066, Oradea · SC RTC Radiology Therapeutic Center SRL /ID# 240744, Otopeni — and 2 more
See the official record ↗ NCT04928846
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
A treatment is being testedPhase 3
Running in: București · Craiova · Florești · Iași · Oradea · Sibiu — and 2 more
See the official record ↗ NCT05211895
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
A treatment is being testedPhase 3
Running in: Clinical Study Site, Baia Mare · Clinical Study Site, București · Clinical Study Site, Cluj-Napoca · Clinical Study Site, Craiova · Clinical Study Site, Iași · Clinical Study Site, Ovidiu — and 2 more
See the official record ↗ NCT06767514
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
A treatment is being testedPhase 2
Running in: Institutul Oncologic Bucuresti "Prof. Dr. Alexandru Trestioreanu", București · Cluj-Napoca · Centrul de Oncologie "Sfântul Nectarie", Craiova · SC Radiotherapy Center Cluj SRL, Florești · S.C. Centrul de Oncologie Euroclinic S.R.L., Iași · Oradea — and 2 more
See the official record ↗ NCT07063745
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
A treatment is being testedPhase 3
Running in: SC ONCO CARD SRL ( Site 2808), Brașov · MEMORIAL HEALTHCARE INTERNATIONAL S.R.L.. ( Site 2803), București · Cardiomed SRL Cluj-Napoca-Medical Oncology ( Site 2801), Cluj-Napoca · Centrul de Oncologie Sfantul Nectarie-Medical ( Site 2805), Craiova · SC Radiotherapy Center Cluj SRL-Oncologie Medicala ( Site 2802), Florești · Institutul Regional de Oncologie ( Site 2807), Iași — and 1 more
See the official record ↗ NCT06312137
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
A treatment is being testedPhase 3
Running in: SC ONCO CARD SRL ( Site 2007), Brașov · Centrul Medical Medicover Victoria ( Site 2000), București · Cardiomed SRL Cluj-Napoca ( Site 2002), Cluj-Napoca · Centrul de Oncologie Sfantul Nectarie-Medical ( Site 2004), Craiova · SC Radiotherapy Center Cluj SRL-Oncologie Medicala ( Site 2001), Florești · Clinica Polisano ( Site 2008), Sibiu — and 1 more
See the official record ↗ NCT06422143
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
A treatment is being testedPhase 2
Running in: Coltea Clinical Hospital, București · Cardiomed, Cluj-Napoca · Onco Clinic Consult SA, Craiova · Centrul de Oncologie Euroclinic srl, Iași · Ovidius Clinical Hospital, Ovidiu · Municipal Hospital Ploiesti, Ploiești — and 1 more
See the official record ↗ NCT06712316
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
A treatment is being testedPhase 3
Running in: SC Oncopremium Team SRL, Baia Mare · Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti (IOB), București · Cardiomed, Cluj-Napoca · Centrul de Oncologie Sf. Nectarie S.R.L (Sf Nectarie Oncology Center), Craiova · Centrul de Oncologie Euroclinic srl, Iași · City Hospital Onesti, Onești — and 1 more
See the official record ↗ NCT06712355
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
A treatment is being testedPhase 3
Running in: Bucharest Oncology Institute Professor Doctor Alexandru Trestioreanu, București · S.C Radiotherapy Center Cluj S.R.L, Cluj-Napoca · S.C Centrul de Oncologie S.F Nectarie SRL, Craiova · Institul Regional de Oncologie lasi;, Iași · S.C Ovidius Clinical Hospital S.R.L, Ovidiu · Spitalul Municipal Ploiesti, Ploiești — and 1 more
See the official record ↗ NCT06801834
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer
A treatment is being testedPhase 3
Running in: București · Craiova · Iași · Otopeni · Pitești · Sibiu — and 1 more
See the official record ↗ NCT06868277
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
A treatment is being testedPhase 3
Running in: Baloteşti · Centrul de Diagnostic si Tratament Provita, București · Institutul Oncologic Cluj, Cluj-Napoca · Centrul de Oncologie "Sfântul Nectarie", Craiova · SC Radiotherapy Center Cluj SRL, Florești · S.C. Centrul de Oncologie Euroclinic S.R.L., Iași — and 1 more
See the official record ↗ NCT07361510
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
A treatment is being testedPhase 3
Running in: Institutul Oncologic, Prof Dr Alexandru Trestioreanu, București · Institutul Oncologic Prof Dr Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Centrul de Oncologie Sf Nectarie SRL, Craiova · Institutul Regional de Oncologie Iasi, Iași · Spitalul Municipal Ploiesti, Ploiești · SC Oncomed SRL, Timișoara
See the official record ↗ NCT05920356
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
A treatment is being testedPhase 3
Running in: SC ONCO CARD SRL ( Site 1995), Brașov · Centrul de Diagnostic si Tratament Provita. ( Site 1992), București · Institutul Oncologic Cluj-Oncologie Medicala ( Site 1999), Cluj-Napoca · Centrul de Oncologie Sfantul Nectarie-Medical ( Site 1994), Craiova · Sigmedical Services SRL ( Site 1997), Suceava · Cabinet Medical Oncomed ( Site 1998), Timișoara
See the official record ↗ NCT06345729
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
A treatment is being testedPhase 3
Running in: Institutul Oncologic Prof. Dr. Alexandru Trestioreanu (IOB); Oncologie Medicala II, București · CardioMed S.R.L., Cluj-Napoca · Sc Oncolab Srl, Craiova · Radiotherapy Center Cluj SRL, Flore?ti · S.C Ovidius Clinical Hospital SRL - Oncology Department, Ovidiu · Oncocenter, Timișoara
See the official record ↗ NCT06452277
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
A treatment is being testedPhase 3
Running in: SC Memorial Healthcare International SRL, București · Institutul Oncologic Cluj, Cluj-Napoca · Centrul de Oncologie "Sfântul Nectarie", Craiova · SC Radiotherapy Center Cluj SRL, Florești · Institutul Regional de Oncologie, Iași · Spitalul Municipal Schuller Ploiești, Ploiești
See the official record ↗ NCT06561386
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A treatment is being testedPhase 3
Running in: SC Memorial Healthcare International SRL, București · SC Medisprof SRL, Cluj-Napoca · SC Oncolab SRL, Craiova · SC Radiotherapy Center Cluj SRL, Florești · Ovidius Clinical Hospital OCH, Ovidiu · S C Oncocenter Oncologie Clinica S R L, Timișoara
See the official record ↗ NCT06758401
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
A treatment is being testedPhase 3
Running in: Delta Health Care S.R.L, București · Institutul Oncologic, Cluj-Napoca · Centrul de Oncologie Sfantul Nectarie Craiova, Craiova · Institutul Regional de Oncologie Lasi, Lasi · S.C R.T.C Radiology Therapeutic Center S.R.L, Otopeni · Spitalul Municipal Ploiesti, Ploiești
See the official record ↗ NCT06899126
A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC)
A treatment is being testedPhase 3
Running in: GSK Investigational Site, Cluj-Napoca · GSK Investigational Site, Craiova · GSK Investigational Site, Craiova Dolj · GSK Investigational Site, Florești · GSK Investigational Site, Iași · GSK Investigational Site, Timișoara
See the official record ↗ NCT07099898
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
A treatment is being testedPhase 3
Running in: SC ONCO CARD SRL ( Site 2109), Brașov · Spitalul Clinic Colțea ( Site 2102), București · Institutul Oncologic Prof. Dr. I Chiricuta ( Site 2103), Cluj-Napoca · Centrul de Oncologie "Sfântul Nectarie" ( Site 2107), Craiova · SC Radiotherapy Center Cluj SRL-Oncologie Medicala ( Site 2101), Florești · Spitalul Municipal Schuller Ploiești ( Site 2106), Ploiești
See the official record ↗ NCT07190248
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
A treatment is being testedPhase 3
Running in: Centrul de Diagnostic si Tratament Provita, București · Institutul Oncologic Cluj, Cluj-Napoca · Centrul de Oncologie Sf. Nectarie SRL, Craiova · SC Radiotherapy Center Cluj SRL, Florești · S.C. Centrul de Oncologie Euroclinic S.R.L., Iași · Oncomed, Timisoara, Timis
See the official record ↗ NCT07361497
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
A treatment is being testedPhase 2
Running in: București · Cluj-Napoca · Craiova · Florești · Iași · Timișoara
See the official record ↗ NCT07680764
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
A treatment is being testedPhase 2
Running in: Institutul Oncologic Bucuresti - Prof. Dr. Alexandru Trestioreanu, București · Medisprof, Cluj-Napoca · Centrul de Radioterapie Amethyst Cluj, Florești · Centrul de Oncologie Euroclinic, Iași · Oncocenter - Oncologie Clinica, Timișoara
See the official record ↗ NCT04613596
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A treatment is being testedPhase 3
Running in: Lotus-Med, București · Institutul Oncologic, Cluj-Napoca · Centrul de Oncologie "Sfântul Nectarie", Craiova · Ovidius Clinical Hospital OCH, Ovidiu · S C Oncocenter Oncologie Clinica S R L, Timișoara
See the official record ↗ NCT06119581
A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
A treatment is being testedPhase 3
Running in: București · Cluj-Napoca · Craiova · Florești · S.C. Centrul de Oncologie Euroclinic S.R.L., Iași
See the official record ↗ NCT06646276
A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)
A treatment is being testedPhase 2
Running in: Institutul Oncologic Bucuresti "Prof. Dr. Alexandru Trestioreanu", București · Institutul Oncologic Cluj, Cluj-Napoca · Centrul de Oncologie "Sfântul Nectarie", Craiova · SC Radiotherapy Center Cluj SRL, Florești · S.C. Centrul de Oncologie Euroclinic S.R.L., Iași
See the official record ↗ NCT06855771
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
A treatment is being testedPhase 2
Running in: București · Cluj-Napoca · Craiova · Florești · Iași
See the official record ↗ NCT07100080
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
A treatment is being testedPhase 3
Running in: S.C Radiotherapy Center Cluj S.R.L, București · Institutul Oncologic 'Prof. Dr. Ion Chiricuta' Cluj Napoca, Cluj-Napoca · S.C Centrul de Oncologie Sfantul Nectarie Craiova, Craiova · S.C. Sigmedical Services Srl, Suceava
See the official record ↗ NCT06203210
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
A treatment is being testedPhase 3
Running in: S.C. ONCO CARD S.R.L ( Site 1805), Brașov · Centrul Medical Medicover Victoria ( Site 1802), București · Institutul Regional de Oncologie ( Site 1804), Iași · Cabinet Medical Oncomed ( Site 1803), Timișoara
See the official record ↗ NCT06623422
A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung Cancer (BENITO Study)
A treatment is being testedPhase 3
Running in: Cluj-Napoca · Craiova · Florești · Timișoara
See the official record ↗ NCT06687369
Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC
A treatment is being testedPhase 2
Running in: "Sf. Nectarie" Oncology Center, Department of Medical Oncology, Craiova · Gral Medical S.R.L. - Oncofort Hospital, Pitești · Clinica Polisano S.R.L., Sibiu · SC Oncomed SRL, Department of Medical Oncology, Timișoara
See the official record ↗ NCT07098988
Volrustomig Priming Regimens Exploratory Phase II Platform Study
A treatment is being testedPhase 2
Running in: Cluj-Napoca · Craiova · Florești
See the official record ↗ NCT06448754
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
A treatment is being testedPhase 3
Running in: Institutul Oncologic Prof. Dr. Ion Chiricuta, Cluj-Napoca · Centrul de Oncologie Sf Nectarie, Craiova · SC OncoMed SRL, Timișoara
See the official record ↗ NCT06472245
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
A treatment is being testedPhase 1
Running in: MNT Healthcare Europe SRL /ID# 269075, București · Institutul Oncologic Prof Dr Ion Chiricuta Cluj Napoca /ID# 268725, Cluj-Napoca · Clinica MedLife Polisano Sibiu /ID# 269078, Sibiu
See the official record ↗ NCT06772623
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
A treatment is being testedPhase 3
Running in: Lotus-Med, București · Institutul Oncologic, Cluj-Napoca · Ovidius Clinical Hospital OCH, Ovidiu
See the official record ↗ NCT06890598
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
A treatment is being testedPhase 3
Running in: Lotus Med, București · Ovidius Clinical Hospital S.R.L, Ovidiu · Polaris Medical S.A., Suceagu/ Cluj Napoca
See the official record ↗ NCT07195695
Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
A treatment is being testedPhase 2
Running in: Sf. Nectarie Oncology Center, Craiova · Clinica Polisano S.R.L, Sibiu · SC Oncomed SRL, Timișoara
See the official record ↗ NCT07246863
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy
A treatment is being testedPhase 3
Running in: Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti, București · Institute Of Oncology Prof. Dr. Ion Chiricuta Cluj-Napoca, Cluj-Napoca · Centrul De Oncologie SF Nectarie S.R.L., Craiova
See the official record ↗ NCT07472517
A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
A treatment is being testedPhase 3
Running in: Oncolab S.R.L., Craiova · Spitalul Clinic Municipal de Urgenta Timisoara/ Clinica de Oncologie Medicala, Timișoara
See the official record ↗ NCT06908304
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
A treatment is being testedPhase 1
Running in: Craiova · Oncohelp Medical Center, Timișoara
See the official record ↗ NCT07325136
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
A treatment is being testedPhase 1
Running in: Arensia Exploratory Medicine, Cluj-Napoca
See the official record ↗ NCT06303505
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A treatment is being testedPhase 3
Running in: Craiova
See the official record ↗ NCT06417814
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)
A treatment is being testedPhase 3
Running in: Institutul Oncologic Prof Dr Ion Chiricuta Cluj-Napoca, Cluj-Napoca
See the official record ↗ NCT07005128
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
A treatment is being testedPhase 1
Running in: Craiova
See the official record ↗ NCT07407933
Observational study: how atezolizumab treatment goes in routine practice, as patients report it
Observational study — you do not receive a new treatment
Running in: Institut Oncologic Prof. Dr. Alexandru Trestioreanu, București · Institutul Regional de Gastroenterologie si Hepatologie Prof. Dr. Octavian Fodor, Cluj-Napoca · Spitalul Clinic Jude?ean de Urgen?? Sfântul Apostol Andrei Galati;oncology, Galați · Institutul Regional de Oncologie Iasi, Iași · Spitalul Municipal Ploiesti, Ploiești · Spitalul Judetean de Urgenta Satu Mare, Satu Mare — and 1 more
Registry title: A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
See the official record ↗ NCT07284121
Source: ClinicalTrials.gov, the public registry of the US National Library of Medicine. Read automatically, last on 31 Jul 2026.
